Detection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery.

OBJECT The authors have shown that convection-enhanced delivery (CED) of gadoteridol-loaded liposomes (GDLs) into different regions of normal monkey brain results in predictable, widespread distribution of this tracking agent as detected by real-time MR imaging. They also have found that this tracking technique allows monitoring of the distribution of similar nanosized agents such as therapeutic liposomes and viral vectors. A limitation of this procedure is the unexpected leakage of liposomes out of targeted parenchyma or malignancies into sulci and ventricles. The aim of the present study was to evaluate the efficacy of CED after the onset of these types of leakage. METHODS The authors documented this phenomenon in a study of 5 nonhuman primates and 7 canines, comprising 54 CED infusion sessions. Approximately 20% of these infusions resulted in leakage into cerebral ventricles or sulci. All of the infusions and leakage events were monitored with real-time MR imaging. The authors created volume-distributed versus volume-infused graphs for each infusion session. These graphs revealed the rate of distribution of GDL over the course of each infusion and allowed the authors to evaluate the progress of CED before and after leakage. RESULTS The distribution of therapeutics within the target structure ceased to increase or resulted in significant attenuation after the onset of leakage. CONCLUSIONS An analysis of the cases in this study revealed that leakage undermines the efficacy of CED. These findings reiterate the importance of real-time MR imaging visualization during CED to ensure an accurate, robust distribution of therapeutic agents.

[1]  Timothy Sendera,et al.  Clinicopathological findings following intraventricular glial‐derived neurotrophic factor treatment in a patient with Parkinson's disease , 1999, Annals of neurology.

[2]  J. Kucharczyk,et al.  Minimally invasive procedures. Interventional MR image-guided functional neurosurgery. , 2001, Neuroimaging clinics of North America.

[3]  S. Kunwar Convection enhanced delivery of IL13-PE38QQR for treatment of recurrent malignant glioma: presentation of interim findings from ongoing phase 1 studies. , 2003, Acta neurochirurgica. Supplement.

[4]  S E Maier,et al.  Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. , 2001, Cancer research.

[5]  R. Sánchez-Pernaute,et al.  Convection-enhanced delivery of AAV-2 combined with heparin increases TK gene transfer in the rat brain , 2001, Neuroreport.

[6]  Jyh-Cheng Chen,et al.  Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  Raphael Pfeffer,et al.  Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. , 2004, Journal of neurosurgery.

[8]  P F Morrison,et al.  Convection-enhanced delivery of macromolecules in the brain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  W. Hall,et al.  The roles of functional MRI in MR-guided neurosurgery in a combined 1.5 Tesla MR-operating room. , 2003, Acta neurochirurgica. Supplement.

[10]  S. Maier,et al.  Convection-enhanced drug delivery: increased efficacy and magnetic resonance image monitoring. , 2005, Cancer research.

[11]  P. Colosi,et al.  Distribution of AAV-TK following Intracranial Convection-Enhanced Delivery into Rats , 2000, Cell transplantation.

[12]  O Ganslandt,et al.  Intraoperative high-field MRI: anatomical and functional imaging. , 2006, Acta neurochirurgica. Supplement.

[13]  Ryuta Saito,et al.  Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain , 2005, Experimental Neurology.

[14]  Raghu Raghavan,et al.  Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions. , 2007, Neuro-oncology.

[15]  P F Morrison,et al.  Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. , 1995, Journal of neurosurgery.

[16]  Mitchel S Berger,et al.  Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Christoph Pedain,et al.  INTRACEREBRAL INFUSATE DISTRIBUTION BY CONVECTION‐ENHANCED DELIVERY IN HUMANS WITH MALIGNANT GLIOMAS: DESCRIPTIVE EFFECTS OF TARGET ANATOMY AND CATHETER POSITIONING , 2007, Neurosurgery.

[18]  John W. Park,et al.  Real-time Imaging and Quantification of Brain Delivery of Liposomes , 2006, Pharmaceutical Research.

[19]  D. Brooks,et al.  Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease , 2003, Nature Medicine.

[20]  W. Pardridge,et al.  Delivery of β-Galactosidase to Mouse Brain via the Blood-Brain Barrier Transferrin Receptor , 2005, Journal of Pharmacology and Experimental Therapeutics.

[21]  William Jagust,et al.  Convection-Enhanced Delivery of AAV Vector in Parkinsonian Monkeys; In Vivo Detection of Gene Expression and Restoration of Dopaminergic Function Using Pro-drug Approach , 2000, Experimental Neurology.

[22]  E. Oldfield,et al.  Selective opening of the blood-tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas. , 2003, Journal of neurosurgery.

[23]  O Ganslandt,et al.  Preliminary experience in glioma surgery with intraoperative high-field MRI. , 2003, Acta neurochirurgica. Supplement.

[24]  S. Gill,et al.  Intraputamenal infusion of glial cell line–derived neurotrophic factor in PD: A two‐year outcome study , 2005, Annals of neurology.

[25]  Yoji Yamashita,et al.  The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  E. Neuwelt,et al.  Single-dose contrast agent for intraoperative MR imaging of intrinsic brain tumors by using ferumoxtran-10. , 2005, AJNR. American journal of neuroradiology.

[27]  Ryuta Saito,et al.  Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imaging. , 2005, Brain research. Brain research protocols.